Javascript must be enabled to continue!
Is It Useful to Question the Recovery Behaviour of Patients with ME/CFS or Long COVID?
View through CrossRef
For the last few decades, medical guidelines have recommended treating patients with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) with graded exercise therapy (GET) and cognitive behavioural therapy (CBT). Moreover, doctors have questioned the recovery behaviour of these patients and stimulated them to follow these treatments so that they would be able to go back to work. In this article, we reviewed trials of GET and CBT for ME/CFS that reported on work status before and after treatment to answer the question of whether doctors should continue to question the recovery behaviour of patients with ME/CFS. Our review shows that more patients are unable to work after treatment than before treatment with CBT and GET. It also highlights the fact that both treatments are unsafe for patients with ME/CFS. Therefore, questioning the recovery behaviour of patients with ME/CFS is pointless. This confirms the conclusion from the British National Institute for Health and Care Excellence (NICE), which has recently published its updated ME/CFS guideline and concluded that CBT and GET are not effective and do not lead to recovery. Studies on CBT and GET for long COVID have not yet been published. However, this review offers no support for their use in improving the recovery of patients with an ME/CFS-like illness after infection with COVID-19, nor does it lend any support to the practice of questioning the recovery behaviour of these patients.
Title: Is It Useful to Question the Recovery Behaviour of Patients with ME/CFS or Long COVID?
Description:
For the last few decades, medical guidelines have recommended treating patients with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) with graded exercise therapy (GET) and cognitive behavioural therapy (CBT).
Moreover, doctors have questioned the recovery behaviour of these patients and stimulated them to follow these treatments so that they would be able to go back to work.
In this article, we reviewed trials of GET and CBT for ME/CFS that reported on work status before and after treatment to answer the question of whether doctors should continue to question the recovery behaviour of patients with ME/CFS.
Our review shows that more patients are unable to work after treatment than before treatment with CBT and GET.
It also highlights the fact that both treatments are unsafe for patients with ME/CFS.
Therefore, questioning the recovery behaviour of patients with ME/CFS is pointless.
This confirms the conclusion from the British National Institute for Health and Care Excellence (NICE), which has recently published its updated ME/CFS guideline and concluded that CBT and GET are not effective and do not lead to recovery.
Studies on CBT and GET for long COVID have not yet been published.
However, this review offers no support for their use in improving the recovery of patients with an ME/CFS-like illness after infection with COVID-19, nor does it lend any support to the practice of questioning the recovery behaviour of these patients.
Related Results
Avaluació d'alternatives industrials per a l'obtenció de nous materials que valoritzen residus queratínics
Avaluació d'alternatives industrials per a l'obtenció de nous materials que valoritzen residus queratínics
The worldwide poultry industry generates a large amount of wastes which, accordingly to the current law, are mostly discarded. These wastes include chicken feathers, keratin struct...
Improvement of Long COVID symptoms over one year
Improvement of Long COVID symptoms over one year
ImportanceEarly and accurate diagnosis and treatment of Long COVID, clinically known as post-acute sequelae of COVID-19 (PASC), may mitigate progression to chronic diseases such as...
Burden of the Beast
Burden of the Beast
Introduction
Throughout the COVID-19 pandemic, and its fluctuating waves of infections and the emergence of new variants, Indigenous populations in Australia and worldwide have re...
Integrated causal inference modeling uncovers novel causal factors and potential therapeutic targets of Qingjin Yiqi granules for chronic fatigue syndrome
Integrated causal inference modeling uncovers novel causal factors and potential therapeutic targets of Qingjin Yiqi granules for chronic fatigue syndrome
Objective:
Chronic fatigue syndrome (CFS) is a prevalent symptom of post-coronavirus disease 2019 (COVID-19) and is associated with unclear disease mechanisms. The herb...
Current therapeutic strategies for erectile function recovery after radical prostatectomy – literature review and meta-analysis
Current therapeutic strategies for erectile function recovery after radical prostatectomy – literature review and meta-analysis
Radical prostatectomy is the most commonly performed treatment option for localised prostate cancer. In the last decades the surgical technique has been improved and modified in or...
Potential benefits of a ketogenic diet to improve response and recovery from physical exertion in people with Myalgic encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): A feasibility study
Potential benefits of a ketogenic diet to improve response and recovery from physical exertion in people with Myalgic encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): A feasibility study
Background: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) affects approximately 250,000 people in the UK. The condition varies in severity causing long-term physical ...
ผลของ Lactobacillus rhamnosus GG ร่วมกับสารเคอคิวมินต่อการยับยั้งการมีชีวิตและกระตุ้นการตายแบบอะพอพโตซิสของเซลล์มะเร็งช่องปากชนิดสความัสเซลล์คาร์ซิโนมา
ผลของ Lactobacillus rhamnosus GG ร่วมกับสารเคอคิวมินต่อการยับยั้งการมีชีวิตและกระตุ้นการตายแบบอะพอพโตซิสของเซลล์มะเร็งช่องปากชนิดสความัสเซลล์คาร์ซิโนมา
มะเร็งช่องปากชนิดสความัสเซลล์คาร์ซิโนมา (Oral squamous cell carcinoma, OSCC) จัดเป็นมะเร็งที่พบได้บ่อยที่สุดของ มะเร็งศรีษะและลำคอ เคอคิวมินเป็นสารออกฤทธิ์หลักซึ่งพบได้ในขมิ้นชันแล...

